Stockscreener 앱 받기
4.07
2.05%
-0.085
전일 마감가:
$4.155
열려 있는:
$3.9501
하루 거래량:
1,203
Relative Volume:
0.01
시가총액:
$16.39M
수익:
-
순이익/손실:
$-117.67M
주가수익비율:
-1.3172
EPS:
-3.09
순현금흐름:
$-101.06M
1주 성능:
-1.93%
1개월 성능:
-1.69%
6개월 성능:
+1,313%
1년 성능:
+571.73%
1일 변동 폭
$3.95
$4.085
1주일 범위
$3.95
$4.23
52주 변동 폭
$0.2195
$4.59
Athira Pharma Inc Stock (ATHA) Company Profile
명칭
Athira Pharma Inc
전화
(425) 620-8501
주소
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
ATHA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
3.95 | 16.39M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.38 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-19 | 다운그레이드 | Mizuho | Outperform → Neutral |
| 2024-09-04 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-09-04 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | 개시 | Rodman & Renshaw | Buy |
| 2022-10-17 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | 개시 | Mizuho | Buy |
| 2022-06-23 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-23 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-05-10 | 개시 | BTIG Research | Buy |
| 2022-04-21 | 개시 | Berenberg | Buy |
| 2021-12-15 | 개시 | Goldman | Neutral |
| 2020-10-13 | 개시 | Goldman | Buy |
| 2020-10-13 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-13 | 개시 | Jefferies | Buy |
| 2020-10-13 | 개시 | Stifel | Buy |
모두보기
Athira Pharma Inc 주식(ATHA)의 최신 뉴스
Why Athira Pharma Inc. stock is popular among millennialsJuly 2025 Trends & Safe Capital Growth Plans - newser.com
Can Athira Pharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
Athira Pharma Inc. stock volume spike explainedQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Will Athira Pharma Inc. continue its uptrendWeekly Trend Summary & High Accuracy Trade Signal Alerts - newser.com
Risk vs reward if holding onto Athira Pharma Inc.Dollar Strength & Free Reliable Trade Execution Plans - newser.com
Will Athira Pharma Inc. stock benefit from AI adoptionCEO Change & Verified Short-Term Plans - newser.com
Real time alert setup for Athira Pharma Inc. performanceInflation Watch & Breakout Confirmation Alerts - newser.com
Is Athira Pharma Inc. stock cheap at current valuationSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Athira Pharma Inc. stock outlook for YEARGap Up & High Accuracy Investment Signals - newser.com
Published on: 2025-11-01 11:59:10 - newser.com
What indicators show strength in Athira Pharma Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
What analyst consensus says on Athira Pharma Inc. stockWeekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-31 05:52:18 - newser.com
Top chart patterns to watch in Athira Pharma Inc.Options Play & Real-Time Volume Spike Alerts - newser.com
What analysts say about Athira Pharma Inc stockFederal Reserve Announcements & Learn From the Strategies of Institutions - earlytimes.in
What makes Athira Pharma Inc. stock attractive to growth fundsRate Cut & High Conviction Buy Zone Alerts - newser.com
Is Athira Pharma Inc. stock ready for breakoutWeekly Trading Summary & Reliable Breakout Stock Forecasts - fcp.pa.gov.br
How to use a screener to detect Athira Pharma Inc. breakoutsTrade Exit Report & Safe Capital Growth Plans - newser.com
How to escape a deep drawdown in Athira Pharma Inc.July 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Athira Pharma Inc (ATHA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):